Nile Albright Research Foundation is a 501(c)(3) that provides Boston area labs the funding they need to make game-changing discoveries in cancer research.
The date has been announced for the Hollis L. Albright Symposium at @harvardmed. Please join us on March 30th for this virtual event featuring speaker Marinka Zitnik, PhD RSVP Here: https://t.co/VgKJoJWP1O
How A Fringe Idea Led To Lifesaving Cancer Treatments https://t.co/lKh9utWHAa via @scifri This interview will be live on the radio (@WBUR, Boston; @WNYCStudios, New York) on air this Friday, Dec 12 at 3:06 ET.
Dr. Rakesh Jain @SteeleLabsMGH shared insights from his decades-long work on vascular normalization—from concept to clinic. His lecture emphasized strategies to improve tumor vessel function and how these principles are transforming cancer therapy at #AACR25@harvardmed
It was great to see our very own Rakesh Jain, PhD, FAACR, from @MGHSteeleLabs receive the Lifetime Achievement in Cancer Research from @AACR at #AACR25!
Congrats! Read more: https://t.co/vS72oKbdnE @MGHCancerCenter
Honored to see Dr. Rakesh K. Jain, recognized with the AACR Award for Lifetime Achievement in Cancer Research at the #AACR25 Annual Meeting in Chicago! @MGHSteeleLabs#CancerResearch
Personalized Career Conversations: At these #AACR25 career sessions (Saturday, April 26), early-career scientists can attend one-on-one meetings with senior investigators to network and get career advice. Pre-registration is required. https://t.co/fGOaeRBSuD
#AACRECR
Caroline Hood is now the third recipient of The Nile Albright Research Foundation Internship for Young Women in Cancer Research at the Moses Lab at @BostonChildrens https://t.co/4gzoy6ZPCn
Congratulations to the recipients of the 2025 AACR Scientific Achievement Awards and Lectureships. This year’s distinguished class of awardees will be recognized at #AACR25 in Chicago. https://t.co/V2FLL89i2U
What an evening! Thank you to the @museumofscience for hosting this event and to Arianna Huffington and special guest Regina Barzilay, PhD, @MIT for leading this discussion on exciting new ways in which AI can be used to improve productivity and health outcomes. @ariannahuff
Our 2025 Event season is ongoing. TONIGHT at 7:00 at the @museumofscience, join us for the Lee & Nile Albright Symposium. Review the highlights from our HLA Symposium at Harvard Medical School held in March in our most recent newsletter below. https://t.co/5gTIa9Ynos
The AACR congratulates Rakesh K. Jain, PhD, FAACR, who will be honored with the 2025 AACR Award for Lifetime Achievement in Cancer Research at #AACR25. https://t.co/ABY2wR6KE9 #AACRFellows@harvardmed@MassGeneralNews
We’re thrilled to share that our director, Dr. Rakesh K. Jain, has been awarded the 2025 AACR Award for Lifetime Achievement in Cancer Research! His pioneering work in tumor microenvironment & vascular normalization has shaped modern cancer therapy.
https://t.co/uIAfIxq62y @AACR
Thursday, April 10, 2025 | 7:00 pm
Don't miss Arianna Huffington with Dr. Regina Barzilay at the Museum of Science. Together they will share their respective groundbreaking work, highlighting how AI improves health outcomes for all. Tickets-$20 https://t.co/DYlO1y7IuP
The 2025 HLA Symposium is over. Thank you, @harvardmed, for hosting this event in person for the first time since 2019. And thank you to our special guest @ReganBergmarkMD for sharing her experience with us. More to come on the event highlights. @G_Q_Daley
Join us as we honor Marta Williams, a remarkable 4th year student @harvardmed and the 2025 Albright Scholar! Discover her inspiring journey and dedication to medicine. Read more about Marta here: https://t.co/lA1r0Xohm2 #AlbrightScholar#FutureDoctors#HollisLAlbrightSymposium
Join HMS Dean for Medical Education Bernard S. Chang, AB ’93, MD, MMSc ’05, to hear about HMS’s efforts to harness the potential of generative AI to transform the classroom and the clinic. Tuesday, March 4th https://t.co/TThJgjaNOe
What are T cells, and what do they do? Explore the different types of T cells, understand their development, and review the consequences of defective T cells, with @Tech_Networks: https://t.co/k28SN68t6B #TCells#Immunotherapy#CancerResearch
From @MGHSteeleLabs ; Their latest study in
@PNASNews reveals that targeting EPHB2/ABL1 with dasatinib reprograms the immune microenvironment, leading to tumor regression in preclinical ependymoma models. https://t.co/BphNRAmLAL